Alerts will be sent to your verified email
Verify Email
SPARC
|
Sun Pharma Adv. Res
|
Dishman Carbogen Amc
|
Zenotech Laboratorie
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
576.14 % | 1.64 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
-64.48 % | -1.15 % | 9.5 % |
|
5yr average Equity Multiplier
|
1.39 | 1.61 | 1.13 |
|
5yr Average Asset Turnover Ratio
|
0.22 | 0.26 | 0.36 |
|
5yr Avg Net Profit Margin
|
-361.01 % | -2.96 % | -13.89 % |
|
Price to Book
|
0.0 | 0.61 | 3.24 |
|
P/E
|
0.0 | 28.67 | 101.54 |
|
5yr Avg Cash Conversion Cycle
|
80.33 Days | 24.66 Days | -1217.81 Days |
|
Inventory Days
|
0.0 | 110.18 Days | 145.01 Days |
|
Days Receivable
|
80.33 Days | 77.38 Days | 61.38 Days |
|
Days Payable
|
0.0 | 156.95 Days | 477.06 Days |
|
5yr Average Interest Coverage Ratio
|
-97.45 | 0.4 | -4.03 |
|
5yr Avg ROCE
|
208.61 % | 0.91 % | 9.71 % |
|
5yr Avg Operating Profit Margin
|
-357.39 % | 13.93 % | 5.56 % |
|
5 yr average Debt to Equity
|
-0.27 | 0.3 | 0.04 |
|
5yr CAGR Net Profit
|
9.0 % | n/a | n/a |
|
5yr Average Return on Assets
|
-68.32 % | -0.73 % | 8.4 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.67 % | 59.32 % | 68.84 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.42 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.77 % | -3.18 % | 0.0 |
|
Sun Pharma Adv. Res
|
Dishman Carbogen Amc
|
Zenotech Laboratorie
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|